May 27, 2016
MSD and Kyorin Holdings announced on May 25 that MSD and Kyorin Pharmaceutical have agreed to alter their existing comarketing deal in Japan for MSD’s investigational anti-allergic agent desloratadine. Under the revised deal, Kyorin Pharmaceutical will acquire exclusive marketing rights...read more